Published by
@ShahidNShah
@ShahidNShah
November 15, 2022
Online
End-stage liver disease (ESLD) is a serious illness marked by significant morbidity and mortality, with a median survival of two years without liver transplantation. Many people first learn of their diagnosis during an acute index hospitalization for debilitating complications of liver failure, such as jaundice, ascites, hepatic encephalopathy, and variceal hemorrhage. Patients who survive this hospitalization are vulnerable—they often have limited prognostic understanding and face social stigma due to their liver disease. It is rare that they experience the engagement of palliative care.
Continue reading at capc.org
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 22, 2024 at 12:50pm